Tag: Novo Nordisk

Corporate Moves January 4, 2023

Investors Worldwide Agreed to Class Action Litigation Settlements Totaling More than $7.4 Billion in 2022

Totals rose more than 75% from 2021.

Regulation August 28, 2019

Pension Funds Sue Novo Nordisk for $1.75 Billion over Alleged Collusion

Lawsuit claims pharmaceutical firm engaged in insulin price fixing, and misled investors.